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Abstract 
Hoof canker is described as progressive pododermatitis of the equine hoof with 
absent epidermal cornification and extensive proliferation of the dermal papillary 
body; however, in-depth research on the type of proliferative activity has not yet 
been reported. The aim of the present study was to determine cell-specific 
proliferation patterns together with morphological analysis of hoof canker tissue. 
Tissues removed during surgery from 19 horses presented for treatment of canker 
were compared to similar postmortem tissues of healthy hooves of 10 horses. 
Morphological alterations visible in light microscopy were assessed semi-
quantitatively and graded for severity. Proliferative activity was evaluated by means 
of anti-PCNA (proliferative cell nuclear antigen) and anti-Ki67 immunohistochemistry. 
Histologically, canker tissue showed five major morphological alterations, the 
presence of lacunae, vacuoles, giant cells, hemorrhage and inflammation, not seen 
in control tissue. Also, there was a notable koilocytotic appearance of keratinocytes 
in canker tissue. Immunohistochemistry revealed increased levels of PCNA protein 
expression in keratinocytes and fibroblasts of canker tissue compared to control 
tissue. In control tissue, keratinocytes showed higher levels of Ki67 compared to 
canker tissue, while the dermal fibroblasts of both groups showed similar levels of 
Ki67, indicating similar proliferative activity of less than 3% of total dermal fibroblasts. 
These results demonstrate that, in contrast to previous reports, there is no evidence 
for increased proliferative activity of the dermal papillary body associated with hoof 
canker. Increased levels of PCNA protein expression and morphological alterations 
indicate dysregulation of keratinocyte differentiation constitutes a key event in equine 
hoof canker development. 
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Equine hoof canker (Pododermatitis chronica verrucosa sive migrans) is described 
as destructive and progressive pododermatitis with alterations in the cornification 
process of the keratinocytes (parakeratosis and hyperkeratosis).15, 24, 26 Extensive 
proliferation of the dermal papillary body with subsequent absence of epidermal 
cornification is reported to be a major feature of disease.23, 24 Hoof canker can affect 
one or more hooves, and compromises the use and welfare of horses due to ensuing 
instability of affected hoof capsules and lameness at late stages. Today, its etiology 
is still unknown. Different theories for the development of hoof canker have been 
reported. Inadequate husbandry, i.e. a lack of hoof hygiene and excessive moisture, 
as well as genetic predispositions, (auto)immune reactions, microorganisms (such as 
fungi, spirochetes and other anaerobic bacteria), as well as bovine papillomaviruses 
have been suggested to be involved in the development of canker .3, 9, 19, 20, 28 
However, for any of these, a causal association with the development of disease 
remains to be established. Morphological studies of hoof canker tissues are rare.24, 26 
Ballooning of the keratinocytes, mainly in the Stratum germinativum of the frog, has 
been reported together with the occurrence of perinuclear vacuoles in the cells of 
deep layers of the Stratum spongiosum; the cells of the corium are covered by a thin 
layer of defective epidermis, leading to an increased risk of infection and bleeding.26 
To our knowledge, the proliferative character of canker has not yet been analyzed in 
detail. Immunohistochemistry allows characterization of tissue proliferation, as has 
been shown in a number of potentially metaplastic or neoplastic tissues.4, 13, 14, 27 
During the proliferative phase of eukaryotic cells, different markers are used to 
determine the proliferative activity in healthy versus pathologically altered tissue.4, 13, 
27 In the present study, antibodies to detect the Ki67 protein and the proliferating cell 
nuclear antigen (PCNA) protein were selected to analyze the proliferative processes 
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in canker tissue. Ki67 is a sensitive, well-established predictive marker for 
recurrence in human breast cancer; it is widely used in tumor diagnostic and cell 
proliferation research.14, 27 PCNA is a marker for proliferation, and, additionally, it 
indicates DNA damage and related repair mechanisms, but can be induced also by 
growth factors independent of the cell cycle.14 Based on the hypothesis that equine 
hoof canker is a proliferative disease, the aim of the present study was to investigate 
the proliferative status and morphological alterations in canker tissue compared to 
healthy hoof tissue. 
 
Materials and Methods  
Sample collection 
Tissues of 19 horses presented for treatment of hoof canker to the Equine University 
Clinic of the University of Veterinary Medicine, Vienna, Austria (Supplemental Table 
1) were assessed. Hoof canker was diagnosed based on its typical clinical 
appearance.1, 23, 24 Tissue samples were taken from superficial regions of canker 
affected areas with a hoof knife on the first day of treatment and from deep regions 
including the dermo-epithelial junction during surgery under regional anesthesia on 
the following day. Tissue sampling and evaluation, as well as anonymized 
publication of the data obtained, were carried out with the written consent of the 
horse owners, given on admission of the horse to the clinic. Sample collection was 
carried out during therapeutic trimming and surgery of affected hooves; all tissues 
used were removed based on clinical necessity. 
Samples of 11 horses euthanized for reasons other than hoof or skin disease were 
used as control tissue (Supplemental Table 1). Prior to inclusion as controls, all 
hooves and areas of skin were examined macroscopically and histologically for 
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absence of pathological alterations. Therefore, hoof tissues of corresponding regions 
of 10/11 horses were sampled post mortem, and skin of 1/11 horse was used for the 
establishment of immunohistochemical (IHC) protocols.  
 
Histology and Immunohistochemistry 
Tissues were cut into 1 x 2 cm pieces for histological embedding. Tissues for 
histological and IHC analysis were immersion-fixed in 4% buffered formaldehyde for 
a minimum of 72 hours and embedded in Paraplast® (Vogel, Giessen, Germany). 
Histological sections of 3µm thickness were cut and stained with haematoxylin and 
eosin (H&E) according to Romeis for morphological analysis.16 For IHC serial 
sections (3 µm) of skin and hoof, tissues were mounted on 3-
aminopropyltriethoxysilane/glutaraldehyde - coated slides. Endogenous peroxidase 
activity was blocked by incubation in 0.6% H2O2 in methanol for 15 min at room 
temperature. A protein block (1.5% normal goat serum) was used to minimize 
unspecific binding of the primary antibody. The unlabeled monoclonal primary 
antibodies (anti-PCNA and anti-Ki67; for sources, pre-treatments and dilutions - see 
Supplemental Table 2) were detected with the ImmunoVision secondary system 
(ImmunoVision Technologies, Brisbane, CA, USA) using DAB (3, 
3´diaminobenzidine-tetrahydrochloride substrate in Tris buffer pH 7.4 and 0.03% 
H2O2) as chromogen. Finally, slides were washed with distilled water, counterstained 
with haemalum, dehydrated and mounted by use of xylene-soluble medium (DPX, 
Fluka, Buchs, Switzerland). Negative controls were obtained by substitution of the 
primary antibodies by PBS. Evaluation of the sections was performed using light 
microscopy (Polyvar, Reichert-Jung, Vienna, Austria) and a digital camera (Nikon, 
Austria). Sections of healthy equine skin were used as positive controls. 
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Morphological analysis 
Three H&E-stained histological sections per tissue sample and two to five tissue 
samples per horse were evaluated. Five frequently occurring alterations of canker 
tissue were analyzed and evaluated in a semi-quantitative setup (Table 1). The 
grading was performed in a blinded way by one person and combined frequency and 
intensity of the respective criteria. The alterations were graded for intensity as mild 
(one point), moderate (two points) or severe (three points) and for frequency 
concerning the occurrence of the respective criterion in less than 20% of the 
examined area (one point), between 20 and 50% (two points) and more than 50% 
(three points). The sum of the grades of all investigated sections per horse was 
calculated and the mean value for each criterion was determined per horse.  
Lacunae were defined as fluid filled cavities with eosinophilic content, vacuoles as 
formations surrounding the nucleus of keratinocytes in different manifestations, giant 
cells presented as enlarged keratinocytes with morphologically intact cytoplasm and 
nucleus, hemorrhage was described as erythrocyte accumulation and tissue based 
neutrophils, lymphocytes and monocytes indicated inflammation. 
 
Scoring of Proliferative Activity 
Proliferative activity was assessed using two antibodies (anti-Ki67, anti-PCNA). The 
nuclei positive for the respective protein were counted in three randomly selected 
fields featuring a minimum of 100 cells per field on two different slides for each tissue 
sample. In three different regions (Stratum basale, Stratum germinativum, and the 
dermal portion at the dermo-epithelial transition zone in the papillae) proliferative 
activity was determined as the number of antibody positive cells as a percentage of 
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total cell number counted per field for each antibody (scoring index). In the present 
study, the Stratum germinativum was defined as the entire proliferative zone of the 
hoof epidermis, combining the single-layered Stratum basale and the proliferative 
cells of the Stratum spinosum. 
   
Statistical analysis 
A linear mixed model using SPSS statistics 20.0 software (IBM; Vienna, Austria) was 
applied to identify significant differences of proliferative activity (determined via 
PCNA and Ki67 protein expression, respectively) between healthy and hoof canker 
affected cell types of the respective regions. Furthermore, a linear mixed model 
followed by Sidak correction was adapted to compare the values of proliferative 
activity between the different regions for each group (hoof canker tissue and control 
tissue). For all statistical tests a p-value ≤ 0.05 was considered significant.  
 
Results 
Clinical findings 
Ten geldings and nine mares (Supplemental Table 1) presenting for hoof canker at 
the Equine University Clinic of the University of Veterinary Medicine, Vienna, Austria, 
from 2011 to 2014 were included in this study. The average age was 15 years (7 – 
24 years). In 10/19 horses only one hoof showed canker, while in 6/19 horses two 
and in 3/19 horses three hooves were affected. Hoof canker was diagnosed in hind 
limbs in 9/31 hooves, whereas front limbs were affected in 22/31 hooves 
(Supplemental Table 1). 
  
Morphological analysis  
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Results of the morphological evaluation of histological sections obtained from hoof 
canker tissue are listed in table 1. The presence of lacunae was mainly observed at 
the end of papillae (Figures 1-3). In mildly affected tissue, vacuoles were detected as 
slim white halos surrounding intact nuclei as revealed by H&E staining. In severely 
affected tissue, nuclei were pyknotic and cells were enlarged and filled with 
perinuclear vacuoles. These cells were referred to as ballooning keratinocytes or 
koilocytotic keratinocytes (Figures 1, 3, 5 and 7). Giant cells (Figure 6) were 
analyzed by frequency only. Hemorrhage in the epidermal tissue was identified on 
basis of erythrocyte accumulation. In all canker tissues signs of inflammation 
including tissue based neutrophils, lymphocytes and monocytes were present in 
varying severity (Figures 4 and 6).  
 
Proliferative Activity  
Immunohistochemical analyses of PCNA and Ki67 protein expression showed layer 
specific differences (Figures 8-11). In control tissue, epidermal PCNA protein 
expression was of lower intensity and frequency in the Stratum basale and the 
Stratum spinosum compared to corresponding canker tissue (Figures 8 and 9). In 
the hoof canker tissue, a high number of PCNA-expressing keratinocyte nuclei were 
located in the Stratum spinosum. In the affected dermis fibroblasts frequently 
showed PCNA expression in the nuclei; this was a less common observation in 
control tissue. The Ki67 protein expression patterns were distinct from PCNA 
expression patterns in both sets of tissues in regard to reactivity and localization 
(Figures 10 and 11). Keratinocyte nuclei expressing Ki67 were predominantly found 
in the Stratum basale and the deep layers of the Stratum spinosum. Ki67-positive 
fibroblasts were rare in both sets of tissues. Negative controls showed no staining in 
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all IHC reactions (Figures 12 and 13), but melanin granules were occasionally 
observed in the Stratum basale and the Stratum spinosum. 
Results of quantitative analysis are summarized in supplemental table 3 and 
presented in figures 14 and 15. The number of PCNA-positive keratinocytes in the 
Stratum basale was significantly higher in canker tissue than in control tissue. A 
similar scenario was observed for the entire Stratum germinativum. In canker tissue, 
the numbers of PCNA-positive keratinocytes in the Stratum basale was significantly 
lower compared to the Stratum germinativum. This significant difference was not 
evident in the control tissue. The number of PCNA-positive dermal fibroblasts was 
significantly smaller than the number of PCNA-positive epidermal cells in canker 
tissue, there was no significant difference in the control tissue. 
The Ki67 protein staining revealed only a small population of positive cells in canker 
and control tissue. In control tissue, proliferative activity of the keratinocytes, as 
determined by Ki67 staining, was higher than in canker tissue in the Stratum basale, 
as well as in the entire Stratum germinativum. In both sets of tissues, the scoring 
index for Ki67 in dermal fibroblasts was similar (< 3%).  
 
Discussion 
Despite the reported higher incidence of hoof canker in hind feet, more than two 
thirds of the affected feet were front feet in this study.20, 25 The main limitation of this 
study was that canker was diagnosed based on its macroscopic appearance in the 
absence of any other gold standard of diagnosis; main outcomes were microscopic 
features, therefore, introducing a potential risk of circular argumentation. 
In the present study, the monoclonal anti-Ki67 antibody detected fewer positive 
keratinocytes in canker tissue compared to control tissue. The protein Ki67 is a 
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highly sensitive marker of proliferating cells in the G1, S and G2 phase as well as 
during mitosis, but it cannot be detected in cells in G0 phase.27 In contrast, PCNA 
IHC staining resulted in significantly more positive keratinocytes in canker tissue 
compared to control tissue, illustrating either a higher proliferative activity or DNA 
damage-related repair mechanisms in canker tissue. The protein PCNA is more 
stably expressed and can also be detected at the end of the cell cycle; in its function 
as a nuclear ring clamp protein, PCNA is also involved in DNA repair mechanisms 
and can therefore be induced also by growth factors independently from the cell 
cycle.14, 33 The detection of elevated numbers of PCNA-positive cells and reduced 
numbers of Ki67-positive cells in the same samples, as found in the present study, 
has already been described in a variety of tumors and normal tissues.2, 6, 10, 17  
Possible scenarios leading to such results include the detection of PCNA protein at 
the end of cell cycle, as well as in non-proliferating cells during DNA repair or growth 
factor activation. Therefore, it is reasonable to find more PCNA positive cells than 
Ki67 positive cells. This also explains, why Ki67 protein is the more sensitive and 
specific marker for proliferative events in tumor diagnosis.6, 10, 17 Based on this 
knowledge, the Ki67 protein expression data in the present study served to 
conclude, that no increase of proliferative activity is observed for the epidermis and 
dermis of canker tissue. 
The protruding tissue, which is so typical for hoof canker, lacked keratinization and 
related desquamation, whilst hypertrophic events abounded, as revealed by lacunae 
formation, ballooning keratinocytes and giant cell formation, demonstrated in the 
present study. These hypertrophic events in combination with loss of tissue integrity 
might explain the typical filamentous or cauliflower-like appearance of hoof canker, 
as the dermal parts start to prolapse due to lack of pressure of the horn capsule; this 
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is an effect often seen after the creation of hoof horn defects, if too little pressure is 
exerted onto the granulation tissue.36 Lack of keratinization becomes apparent 
through epidermal cells, which remain spherical, thus creating a larger tissue volume 
without hyper-proliferating. In addition, the production of abnormal quantities or types 
of cell proteins possibly contributes to the clinical picture of extensive growth and 
white cheesy exudate.5, 21 
In contrast to other descriptions of canker, the present study provides no evidence of 
increased proliferative activity.19, 30 Yet, hypertrophy and DNA damage with 
subsequent disturbance of keratinization of epidermal cells were frequently 
encountered. 
Not surprisingly, hemorrhage was observed in 18 of 19 surgical hoof canker 
samples. The hemorrhage was potentially enhanced by detected inflammatory 
processes also present in all canker tissues. Inflamed regions were commonly found 
in and adjacent to the dermal papillae, potentially induced by reduced tissue 
cohesion between maldifferentiated, not cornified epidermis and corium. A high 
number of free connective tissue cells were observed in the dermal portion of the 
dermo-epithelial zone and in the dermal papillae as additional sign of inflammation. 
Some samples contained bacteria, as the barrier function of the epidermis is 
impaired with the cessation of keratinocyte differentiation. This is similar to previous 
reports, that bacterial infection is an inconsistent finding in hoof canker.31 
In most hoof canker samples, formation of large epidermal lacunae was observed; 
these lacunae were filled with eosinophilic fluid and might result from accumulation 
or increased production of this fluid (Figure 2). Lacunae formation is suggested to be 
related to instability of the epidermal tissue.18, 32 The instability of the hoof capsule is 
a common cause for canker-associated lameness in late stages of the disease.30 
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Hoof canker-associated keratinocytes are commonly described as “ballooning 
keratinocytes” because of higher cell volumes, pyknotic nuclei and perinuclear 
vacuoles, which was also found in the present study.19, 24 In human keratinocytes, 
human papillomavirus type 16 (HPV-16)-induced changes include comparable 
alterations of the keratinocytes (and human cervical cells in vitro) described as 
koilocytotic cells. These cells feature perinuclear vacuoles appearing as white halos 
and mostly acentric, hyperchromatic nuclei.11, 12 The same cellular appearance is 
also reported for other virus-infected cells, including Molluscum Contagiosum, a 
poxvirus infection in humans, leading to cutaneous lesions with acanthosis, 
hyperkeratosis and nuclear atypia including koilocytotic keratinocytes.29 Therefore, 
koilocytosis observed in keratinocytes of equine hoof canker tissue may refer to a 
potential viral involvement in etiology. The success of local cisplatin chemotherapy 
for equine hoof canker is comparable to the success of intralesional cisplatin 
chemotherapy for papillomaviral-induced equine sarcoids, which is a well-
documented therapy for this disease.1, 7, 34, 35 In addition, the increased expression of 
PCNA protein in hoof canker-associated keratinocytes is another parallel with 
symptoms of viral infection, as, in human keratinocytes in vitro, PCNA expression is 
down-regulated by growth inhibition via TGFß or calcium induced differentiation, 
while in HPV transformed keratinocytes this effect was reduced and PCNA 
expression was still high.8 These observations support the concept of 
papillomaviruses being involved in the development of equine hoof canker, although 
the causal association with onset and progression still remains to be established.3 
Still, neither morphological analyses, nor detected proliferative activity of hoof canker 
tissue revealed evidence of neoplastic transformation of cells of the papillary body. In 
differentiated keratinocytes reduced PCNA levels were found, which might also 
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explain the significantly higher PCNA levels in the poorly differentiated keratinocytes 
in hoof canker.8, 22 Together with the acanthosis seen in most samples, this is 
additional evidence that hoof canker is related to disturbances in differentiation of the 
keratinocytes rather than a proliferative dysfunction. 
The results of the present study suggest that hoof canker is not a hyperproliferative 
process of the dermal papillary body shown by immunohistochemical anti-Ki67 
detection, but increased levels of PCNA protein expression and observed 
morphological alterations indicate that dysregulation of keratinocyte differentiation 
constitutes a key event in equine hoof canker development.  
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Figure legends 
Figures 1-7. Hoof canker, equine, hematoxylin and eosin stain. Figure1: Enlarged, 
fluid filled lacunae (L) are surrounded by enlarged keratinocytes with an increased 
amount of lightly eosinophilic to clear cytoplasm surrounding the nucleus (ballooning 
degeneration of the keratinocytes). Figure 2: Lacunae (L) are encircled by a thin 
membrane-like structure (arrows). Figure 3: Normal keratinocyte nuclei are 
surrounded by a white halo and the cytoplasm contains variably sized eosinophilic 
droplets. Beside intracellular localization, eosinophilic droplets can also be observed 
within the lacunae.  Figure 4: High numbers of inflammatory cells (mostly 
eosinophilic and neutrophil granulocytes) were observed in the corium near the intact 
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Stratum germinativum (SG). Figure 5: Regions of moderate ballooning degeneration 
of keratinocytes (top and middle right hand side) are present near regions of normal 
Stratum germinativum (SG) and regions around the dermal papillae (DP). Figure 6: 
Scattered cells within the normal stratum germinativum were karyomegalic (giant 
cells) and had a perinuclear clear halo (arrows). Figure 7: Area of clear demarcation 
(arrows) between the normal Stratum germinativum (SG) and the keratinocytes with 
ballooning degeneration.  
 
Figures 8-13. Immunohistochemical analysis of PCNA and Ki67 protein expression 
in canker tissue and control hoof tissue. Figure 8: Canker tissue, PCNA protein was 
mainly observed in epithelial cells of the Stratum basale (arrows), the whole of the 
Stratum germinativum (SG) and in fibroblasts within the dermal papillae (DP). Figure 
9: Control hoof tissue, strong anti-PCNA staining was observed in keratinocytes of 
the Stratum basale (arrows) and in keratinocytes of the Stratum germinativum. In the 
dermal papillae fibroblasts were negative for PCNA. Figure 10: Canker tissue, Ki67 
protein expression was restricted to the Stratum basale (arrows) and the deep layers 
of the Stratum spinosum within the Stratum germinativum (SG). Scattered fibroblasts 
were positive for anti-Ki67 staining in the dermal papillae (DP). Figure 11: Control 
tissue, keratinocytes were positive for the Ki67 protein in the Stratum basale (arrow) 
and the deep layers of the Stratum spinosum within the Stratum germinativum (SG), 
whereas a smaller number of dermal fibroblasts were positive in the dermal papillae 
(DP). Figures 12 and 13: Hoof canker, negative controls for the anti-PCNA (Figure 
12) and anti-Ki67 (Figure 13) immunohistochemical stain. Melanin granules (arrows) 
were occasionally observed in the Stratum germinativum. 
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Figures 14 and 15. Evaluation of the percentage of anti-PCNA (Figure 14) and anti-
Ki67 (Figure 15) positive nuclei in the keratinocytes of the Stratum basale and the 
total Stratum germinativum, and the fibroblasts of the dermal connective tissue in 
canker samples (n = 19) and control samples (n = 10). Identical characters (a - e) 
indicate significant differences (p ≤ 0.05) between the groups and regions.  
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Table 1: Summary of the semi-quantitative evaluation of morphological alterations 
performed on histological sections of 19 hoof canker affected horses; the grading 
combined frequency and intensity of the respective criterion. 
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Supplemental table 1: Clinical data of hoof canker affected horses (1-19) and control horses (20-30) 
presented in this study. G gelding; M mare; S stallion; R right; L left; H hind hoof; F front hoof 
 
horse 
 
sex  
 
age (years) 
 
breed 
 
hoof/hooves 
1 
 
G 
 
9 
 
Warmblood   
 
RH 
2 
 
G 
 
13 
 
Holsteiner 
 
LF 
3 
 
G 
 
15 
 
Pinto 
 
LF 
4 
 
G 
 
13 
 
Holsteiner 
 
LH, RH 
5 
 
M 
 
15 
 
Noriker 
 
LF, RF, RH 
6 
 
M 
 
18 
 
Arabian  
 
LH 
7 
 
M 
 
15 
 
Warmblood   
 
LF 
8 
 
M 
 
12 
 
Trotter 
 
LF, RF 
9 
 
G 
 
8 
 
Kladruber 
 
LF, LH, RH 
10 
 
G 
 
16 
 
Warmblood   
 
LF 
11 
 
M 
 
16 
 
Haflinger 
 
LF, RF 
12 
 
M 
 
24 
 
Trotter 
 
LF, RF 
13 
 
G 
 
18 
 
Warmblood   
 
LF, RF, LH 
14 
 
M 
 
11 
 
Noriker 
 
LF 
15 
 
M 
 
16 
 
Trotter 
 
RF 
16 
 
G 
 
15 
 
Hanoverian 
 
LF, RF 
17 
 
G 
 
7 
 
Warmblood   
 
RH 
18 
 
G 
 
20 
 
Trotter 
 
LF, RF 
19 
 
M 
 
18 
 
Trotter 
 
RF 
20  M  14  Warmblood  LF 
21  M  16  Shagya Arabian  RF, RH 
22  G  7  Trotter  LH 
23  S  8  Noriker  RH 
24  M  14  Haflinger  RH 
25  S  2  Lusitano  RH 
26  G  6  Lusitano  LF, RF 
27  G  17  Warmblood  LH, RH 
28  M  4  Quater Horse  RF 
29  M  6  Warmblood  LF 
30  M  17  Tinker  skin 
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Supplemental Table 2: Sources, pre-treatments and dilutions of the antibodies used 
in this study. 
 
Antibody 
 
Source 
 
Clone 
 
Pretreatment 
 
Dilution 
anti-Ki67 
 
Thermo Fisher 
Scientific, 
Fremont, CA, 
USA 
 
SP6 
rabbit  
citrate buffer, 
pH 6.0, 2 hours 
at 85°C 
 
1 : 400 
anti-PCNA 
 
NeoMarkers, 
Fremont, CA, 
USA 
 
PC10  
mouse  
citrate buffer, 
pH 6.0, 2 hours 
at 65°C 
 
1 : 1000 
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Supplemental table 3: Relative amount of positive cells stained for PCNA and Ki67 protein by means 
of immunohistochemistry in three different regions of hoof canker affected horses (n = 19) and the 
control group (n = 10). The values are mean values ± SDs. 
 
 
Scoring index PCNA 
 
Scoring index Ki67 
 
Hoof canker 
 
Control 
 
Hoof canker 
 
Control 
Stratum basale 75.55 ± 27.68 
 
26.62 ± 16.05 
 
28.93 ± 22.54 
 
38.13 ± 9.88 
Stratum germinativum  87.90 ± 21.96 
 
50.88 ± 17.80 
 
32.96 ± 16.08 
 
53.32 ± 11.21 
Fibroblasts (Corium) 37.75 ± 29.86 
 
24.07 ± 10.73 
 
2.22 ± 0.71 
 
1.20 ± 0.45 
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